Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
University of California, Irvine
ClinicalTrials.gov Identifier:
NCT00319839
First received: April 27, 2006
Last updated: January 13, 2010
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2010
  Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)